NV
Northpond Ventures Portfolio holdings
AUM
$43.7M
This Quarter Return
-18.08%
1 Year Return
-34.02%
3 Year Return
-71.84%
5 Year Return
–
10 Year Return
–
AUM
$60.2M
AUM Growth
+$60.2M
(-66%)
Cap. Flow
-$94.3M
Cap. Flow
% of AUM
-156.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$94.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIGL
1
DELISTED
Vigil Neuroscience
VIGL
| $39.6M | 65.75% | 4,214,498 | – | – |
|
|
TBIO
2
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $15.6M | 25.82% | 9,844,130 | – | – |
|
|
CELL
3
DELISTED
PhenomeX Inc. Common Stock
CELL
| $2.64M | 4.38% | 5,390,820 | – | – |
|
4
Candel Therapeutics
CADL
$318M
| $2.44M | 4.05% | 1,935,215 | – | – |
|
|
DICE
5
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| – | – | -3,292,871 | Closed | -$94.3M |
|